{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:33Z","timestamp":1786985073988,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.bcp.2012.12.023","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T13:04:26Z","timestamp":1358514266000},"page":"965-976","source":"Crossref","is-referenced-by-count":23,"title":["Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3"],"prefix":"10.1016","volume":"85","author":[{"given":"Sooho","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Kyeom","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Min","family":"Ra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wonchae","family":"Choe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insug","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohun","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2012.12.023_bib0005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Canto","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0010","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nrc3174","article-title":"Molecular mechanisms of cancer development in obesity","volume":"11","author":"Khandekar","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2012.12.023_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd3055","article-title":"Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases","volume":"9","author":"Cao","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2012.12.023_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00041433-200202000-00008","article-title":"Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin","volume":"13","author":"Havel","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0025","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00240-9","article-title":"Obesity and the regulation of energy balance","volume":"104","author":"Spiegelman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2012.12.023_bib0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri2921","article-title":"Adipokines in inflammation and metabolic disease","volume":"11","author":"Ouchi","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despres","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2012.12.023_bib0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1471-4914(01)02266-3","article-title":"Glycogen synthase kinase 3: an emerging therapeutic target","volume":"8","author":"Eldar-Finkelman","year":"2002","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.bcp.2012.12.023_bib0045","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1073\/pnas.93.20.10707","article-title":"Increased glycogen accumulation in transgenic mice overexpressing glycogen synthase in skeletal muscle","volume":"93","author":"Manchester","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2012.12.023_bib0050","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/WNL.0b013e3181d3e44b","article-title":"Glycogen metabolism: metabolic coupling between astrocytes and neurons","volume":"74","author":"Benarroch","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.bcp.2012.12.023_bib0055","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/35096075","article-title":"The renaissance of GSK3","volume":"2","author":"Cohen","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.tips.2004.07.006","article-title":"Pharmacological inhibitors of glycogen synthase kinase 3","volume":"25","author":"Meijer","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bcp.2012.12.023_bib0065","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2008.00085.x","article-title":"Glycogen synthase kinase 3: more than a namesake","volume":"156","author":"Rayasam","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nrd2999","article-title":"Targeting protein kinases in central nervous system disorders","volume":"8","author":"Chico","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bcp.2012.12.023_bib0075","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2741\/3324","article-title":"GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics","volume":"14","author":"Wada","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.bcp.2012.12.023_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/bj20021535","article-title":"The specificities of protein kinase inhibitors: an update","volume":"371","author":"Bain","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2012.12.023_bib0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/0264-6021:3510095","article-title":"Specificity and mechanism of action of some commonly used protein kinase inhibitors","volume":"351","author":"Davies","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.bcp.2012.12.023_bib0090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/med.20119","article-title":"Preclinical efficacy on GSK-3 inhibitors: towards a future generation of powerful drugs","volume":"28","author":"Martinez","year":"2008","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bcp.2012.12.023_bib0095","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1101\/gad.10.9.1096","article-title":"ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism","volume":"10","author":"Kim","year":"1996","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2012.12.023_bib0100","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0105","doi-asserted-by":"crossref","first-page":"33067","DOI":"10.1074\/jbc.M212635200","article-title":"Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0110","doi-asserted-by":"crossref","first-page":"33902","DOI":"10.1074\/jbc.M802537200","article-title":"AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver","volume":"283","author":"Horike","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0115","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00125-005-0016-3","article-title":"Insulin signalling downstream of protein kinase B is potentiated by 5\u2032AMP-activated protein kinase in rat hearts in vivo","volume":"48","author":"Longnus","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.bcp.2012.12.023_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2121-9-11","article-title":"Effects of GSK3 inhibitors on in vitro expansion and differentiation of human adipose-derived stem cells into adipocytes","volume":"9","author":"Zaragosi","year":"2008","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bcp.2012.12.023_bib0130","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1210\/en.2008-0687","article-title":"Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal","volume":"149","author":"Sen","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.bcp.2012.12.023_bib0135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nm979","article-title":"Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor","volume":"10","author":"Sato","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bcp.2012.12.023_bib0140","doi-asserted-by":"crossref","first-page":"45020","DOI":"10.1074\/jbc.M407050200","volume":"279","author":"Liu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0145","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.bcp.2012.12.023_bib0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/clpt.2011.82","article-title":"New drug targets for the treatment of obesity","volume":"90","author":"Powell","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bcp.2012.12.023_bib0155","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.cellbio.16.1.145","article-title":"Molecular regulation of adipogenesis","volume":"16","author":"Rosen","year":"2000","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0160","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1101\/gad.948702","article-title":"C\/EBPalpha induces adipogenesis through PPARgamma: a unified pathway","volume":"16","author":"Rosen","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2012.12.023_bib0165","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1128\/MCB.00441-06","article-title":"Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin","volume":"26","author":"Liu","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2012.12.023_bib0170","doi-asserted-by":"crossref","first-page":"9509","DOI":"10.1074\/jbc.M411648200","article-title":"Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells","volume":"280","author":"MacAulay","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0175","doi-asserted-by":"crossref","first-page":"29698","DOI":"10.1074\/jbc.272.47.29698","article-title":"The regulation of glycogen synthase by protein phosphatase 1 in 3T3-L1 adipocytes. Evidence for a potential role for DARPP-32 in insulin action","volume":"272","author":"Brady","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0180","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00018-007-7006-1","article-title":"Glycogen synthase 2 is a novel target gene of peroxisome proliferator-activated receptors","volume":"64","author":"Mandard","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bcp.2012.12.023_bib0185","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1152\/ajpendo.00176.2006","article-title":"Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue","volume":"291","author":"Ciaraldi","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bcp.2012.12.023_bib0190","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1152\/ajpendo.00547.2004","article-title":"Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle","volume":"288","author":"Dokken","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bcp.2012.12.023_bib0195","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1046\/j.1432-1033.2003.03777.x","article-title":"Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase","volume":"270","author":"MacAulay","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.bcp.2012.12.023_bib0200","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/diabetes.51.7.2190","article-title":"Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle","volume":"51","author":"Nikoulina","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.12.023_bib0205","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/diabetes.52.3.588","article-title":"Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo","volume":"52","author":"Ring","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.12.023_bib0210","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2337\/db08-0691","article-title":"Insulin reduces cerebral ischemia\/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta","volume":"58","author":"Collino","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2012.12.023_bib0215","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res"},{"key":"10.1016\/j.bcp.2012.12.023_bib0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.105.090266","article-title":"Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob\/ob mice: molecular characterization in liver and muscle","volume":"316","author":"Kaidanovich-Beilin","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bcp.2012.12.023_bib0225","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.00628.2005","article-title":"Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats","volume":"291","author":"Dokken","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.bcp.2012.12.023_bib0230","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.vph.2010.09.004","article-title":"Atherosclerosis induced by a high-fat diet is alleviated by lithium chloride via reduction of VCAM expression in ApoE-deficient mice","volume":"53","author":"Choi","year":"2010","journal-title":"Vascul Pharmacol"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212008313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295212008313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T08:02:18Z","timestamp":1539936138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295212008313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0006295212008313"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2012.12.023","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}